Exact Mass: 300.027
Exact Mass Matches: 300.027
Found 52 metabolites which its exact mass value is equals to given mass value 300.027,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Demethylwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
UXN2KXV8BB
Demethylwedelolactone is a member of coumestans. Demethylwedelolactone is a natural product found in Sphagneticola calendulacea, Eclipta alba, and other organisms with data available. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
Emodic acid
Emodicacid is a member of anthracenes.
Norwedelolactone
Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2]. Demethylwedelolactone is a naturally occurring coumestan isolated from Eclipta alba. Demethylwedelolactone is a potent trypsin inhibitor with an IC50 of 3.0 μM. Demethylwedelolactone suppresses cell motility and cell invasion of breast cancer cell[1][2].
STA-0DC (TENTATIVE)
TENTATIVELY IDENTIFIED SPECTRUM ONLY!!!!!!!!!; BASE PEAK ARISES FROM CO-ELUTING COMPOUND!!!!!; Extracted (without noise removal) from ZUE_N: mz299_02_rt8_95_HCD60_STA-0DC; CONFIDENCE Tentative identification: best match only (Level 3)
2-chloro-N-[3-(trifluoromethyl)phenyl]pyridine-3-carboxamide
Glycine, N-(carboxymethyl)-N-2-(carboxymethyl)aminoethyl-, trisodium salt
2-NITRO-1-(2-PYRIDYLTHIO)-4-(TRIFLUOROMETHYL)BENZENE
sodium,4-[2-(4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]benzenesulfonate
methyl 1-(3,4-dichlorophenyl)-4-oxocyclohexane-1-carboxylate
2-BENZO[1,3]DIOXOL-5-YL-6-CHLORO-IMIDAZO[1,2-A]PYRIDINE-3-CARBALDEHYDE
3-(1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)PYRIDIN-2-AMINE
4-HYDROXY-6-OXO-1-(3-(TRIFLUOROMETHYL)PHENYL)-1,6-DIHYDROPYRIDAZINE-3-CARBOXYLIC ACID
(R)-3-(1-(2,6-Dichloro-3-fluorophenyl)ethoxy)pyridin-2-amine
4-phenyl-1-(trideuteriomethyl)pyridin-1-ium,iodide
2-(4-bromo-2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-Bromomethyl-4-fluorophenylboronic acid neopentyl glycol ester
methyl (2Z,4Z)-5-chloro-2-(chloromethyl)-5-(4-methoxyphenyl)penta-2,4-dienoate
2-(1,3,4-Oxadiazol-2-yl)phenyl 4-chlorobenzenecarboxylate
6-Hydroxy-11-methyl-13-(trifluoromethyl)-8-thia-3,10-diazatricyclo[7.4.0.0^{2,7}]trideca-1(9),2(7),5,10,12-pentaen-4-one
5,6-Bis[(2-hydroxyethyl)sulfanyl]benzimidazole-4,7-quinone
4-[5-(2-Chlorophenyl)-1,2,4-oxadiazol-3-yl]benzoic acid
6-Oxo-1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid
An arenesulfonic acid that is 1,6-dihydrodibenzo[cd,g]indazole-3-sulfonic acid substituted by an oxo group at position 6.
2-[(2,2-dichloro-3,3-dimethylcyclopropyl)methylthio]-1H-benzimidazole
4-(5-(3-Chlorophenyl)-1,2,4-oxadiazol-3-yl)benzoic acid
N3-(4-chlorophenyl)-4-(trifluoromethyl)nicotinamide
phosphatidylglycerol (18:2/16:1)
A phosphatidylglycerol 34:3 in which the acyl group at position 1 contains 18 carbons and two double bonds while that at position 2 contains 16 carbons and 1 double bond.
